131 related articles for article (PubMed ID: 36273983)
1. To study the effect of 'Covishield' vaccination on pre-donation platelet counts of plateletpheresis donors.
Tomar A; Biswas AK; Pawar A; Dimri U; Kumar D; Baranwal AK
Hematol Transfus Cell Ther; 2023; 45(4):456-460. PubMed ID: 36273983
[TBL] [Abstract][Full Text] [Related]
2. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
Nomani L; Raina TR; Sidhu M
Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
[TBL] [Abstract][Full Text] [Related]
4. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine humoral response in frequent platelet donors with plateletpheresis-associated lymphopenia.
Laumaea AE; Lewin A; Chatterjee D; Marchitto L; Ding S; Gendron-Lepage G; Goyette G; Allard MÈ; Simard C; Tremblay T; Perreault J; Duerr R; Finzi A; Bazin R
Transfusion; 2022 Sep; 62(9):1779-1790. PubMed ID: 35919021
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and causes of pre-donation deferrals among potential plateletpheresis donors at a blood center in Eastern China.
Zhu H; Wang J; Lin H
Transfus Clin Biol; 2023 May; 30(2):189-194. PubMed ID: 36257581
[TBL] [Abstract][Full Text] [Related]
8. Recovery of Platelet Count among Apheresis Platelet Donors.
Thokala RP; Radhakrishnan K; Anandan A; Panicker VK
J Clin Diagn Res; 2016 Dec; 10(12):EC01-EC04. PubMed ID: 28208861
[TBL] [Abstract][Full Text] [Related]
9. Pseudothrombocytopenia in plateletpheresis donors.
Sweeney JD; Holme S; Heaton WA; Campbell D; Bowen ML
Transfusion; 1995 Jan; 35(1):46-9. PubMed ID: 7998068
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
[TBL] [Abstract][Full Text] [Related]
11. Donor deferral characteristics for plateletpheresis at a tertiary care center in India- a retrospective analysis.
Pujani M; Jyotsna PL; Bahadur S; Pahuja S; Pathak C; Jain M
J Clin Diagn Res; 2014 Jul; 8(7):FC01-3. PubMed ID: 25177566
[TBL] [Abstract][Full Text] [Related]
12. Plateletpheresis donor deferral pattern: A retrospective 4-year data analysis at tertiary care center in India.
Yadav BK; Shrivastava H; Katharia R; Chaudhary RK
Asian J Transfus Sci; 2022; 16(2):214-218. PubMed ID: 36687534
[TBL] [Abstract][Full Text] [Related]
13. Generation of reticulated platelets in response to whole blood donation or plateletpheresis.
Gyongyossy-Issa MI; Miranda J; Devine DV
Transfusion; 2001 Oct; 41(10):1234-40. PubMed ID: 11606821
[TBL] [Abstract][Full Text] [Related]
14. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
Tondon R; Pandey P; Chaudhry R
J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
[TBL] [Abstract][Full Text] [Related]
16. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
17. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
18. Total platelet donation count and donation frequency are determinants of plateletpheresis-associated lymphopenia.
Thuer L; Brosig A; Hutchinson JA; Hähnel V; Offner R; Burkhardt R; Ahrens N
Transfusion; 2021 Nov; 61(11):3161-3173. PubMed ID: 34545947
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
Woodall WJ; Nguyen VQ; Tran MH
J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
[TBL] [Abstract][Full Text] [Related]
20. Changes in hematological parameters post plateletpheresis: Single center study from North India.
Rajput S; Makroo RN; Chowdhry M; Thakur UK
Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
